牛皮关节炎的临床方面:一年的审查 2024年 2024年
Lorenzo Esti1, Federico Fattorini1, Cosimo Cigolini1
1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Clinical and experimental rheumatology
|January 23, 2025
概括
牛皮关节炎 (PsA) 管理面临挑战,尽管有新的有效药物. 本综述涵盖了关于PsA治疗和并发症的最新文献 (2022-2024年),突出了改善患者结果的领域.
科学领域:
- 类风湿病学 类风湿病学
- 炎症性疾病 炎症性疾病
- 皮肤病学 皮肤病学
背景情况:
- 牛皮关节炎 (PsA) 是一种复杂的炎症状况,与牛皮有关.
- 它呈现出各种共同疾病,影响患者的预后和生活质量.
- 虽然新疗法显示出有效性和安全性,但在某些患者中仍然存在低于最佳的治疗方法.
研究的目的:
- 审查最近在牛皮关节炎治疗方面的进展.
- 分析并发症对PSA管理的影响.
- 识别患者护理中的挑战和潜在改进.
主要方法:
- 关于牛皮关节炎的综合文献搜索.
- 包括2022年1月1日至2024年7月1日期间发表的研究.
- 综合了关于药物的疗效,安全性和患者结果的研究结果.
主要成果:
- 最近的药物开发表明显著的缓解症状和有利的安全性.
- 一部分患者对目前的治疗方法没有反应或改善程度有限.
- 伴随性疾病显著影响疾病负担和治疗有效性.
结论:
- 尽管治疗方面取得了进展,但牛皮关节炎的治疗需要进一步优化.
- 解决不响应和有限的结果对于改善患者护理至关重要.
- 整合并发症管理对于改善PsA患者的预后和生活质量至关重要.
相关概念视频
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
COPD: Pathogenesis and Clinical Features
228
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
228
Autoimmune Disorders
384
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
384
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Parkinson's Disease: Overview
452
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
452


